Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Correction to: Effectiveness and tolerability of lidocaine 5% spray in the treatment of lifelong premature ejaculation patients: a randomized single-blind placebo-controlled clinical trial

The Original Article was published on 02 January 2020

Correction to: International Journal of Impotence Research

https://doi.org/10.1038/s41443-019-0225-9

In the published article the following incorrect statement appeared in the Patients and methods section:

Group 1 (n = 75); was given on demand lidocaine 5% spray for 8 weeks (One to two applications (1–2 ml) of lidocaine 5% sprays; contain 5–10 mg of lidocaine, in a metered-dose aerosol-delivery system) (Lidocaine topical aerosol U.S.P. 38, The Arab Drug Co, Cairo, Egypt). Group 2 (n = 75); was given placebo in the form on demand alcohol spray for 8 weeks (One to two applications (1–2 ml) of alcohol 40% sprays).

The statement should read as follows:

Group 1 (n = 75); was given on demand lidocaine 5% spray for 8 weeks (One to two applications (0.1–0.2 ml) of lidocaine 5% sprays; contain 5–10 mg of lidocaine, in a metered-dose aerosol-delivery system) (Lidocaine topical aerosol U.S.P. 38, The Arab Drug Co, Cairo, Egypt). Group 2 (n = 75); was given placebo in the form on demand alcohol spray for 8 weeks (One to two applications (0.1–0.2 ml) of alcohol 40% sprays).

This has been corrected in both the PDF and HTML versions of the Article.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Mohammed Abu El-Hamd.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

El-Hamd, M.A. Correction to: Effectiveness and tolerability of lidocaine 5% spray in the treatment of lifelong premature ejaculation patients: a randomized single-blind placebo-controlled clinical trial. Int J Impot Res 32, 367 (2020). https://doi.org/10.1038/s41443-020-0229-5

Download citation

Search

Quick links